Process improvements and in-person monitoring help U.S. pharmaceutical company achieve on time for Phase III clinical trials
Impact Pharmaceutical Services
SEPTEMBER 20, 2023
Syner-G experts were onsite to assist the CDMO during the entire campaign. In- person trainings were provided for all stakeholders of the CDMO at appropriate intervals during the campaign. The same was executed to identify a more robust process. Syner-G provided technical expertise for IND amendment.
Let's personalize your content